Global Neurovascular Intervention Market – Cerebral Thrombectomy Devices, Flow Diverter for Aneurysm and Carotid Artery Stenting (CAS) System Market Outlook 2022
Minimally invasive procedures and emergence of new techniques such as MicroNet Mesh for Embolic Prevention and Flow Diversion has been latest trends in the global neurovascular intervention market. The report “Global Neurovascular Intervention Market – Cerebral Thrombectomy Devices, Flow Diverter for Aneurysm and Carotid Artery Stenting (CAS) System Market Outlook 2022” provides an in-depth analysis of neurovascular intervention market overall as well as major market segments such as Cerebral Thrombectomy Devices, Flow Diverter for Aneurysm and Carotid Artery Stenting (CAS) System. Market outlook for overall neurovascular intervention market as well as aforementioned sub-segments has been provided for the period 2017-22.
The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market specific growth opportunities in global neurovascular intervention market. The report has been segmented as following:-
Market Segmentation
The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market specific growth opportunities in global neurovascular intervention market. The report has been segmented as following:-
Market Segmentation
- Cerebral Thrombectomy Devices
- Flow Diverter for Aneurysm
- Carotid Artery Stenting (CAS) System
- Global
- The US
- Johnson & Johnson DePuy Synthes
- Stryker Corporation
- Medtronic Plc.
- Penumbra Inc.
- Terumo Corporation
1. EXECUTIVE SUMMARY
2. RESEARCH METHODOLOGY
3. NEUROVASCULAR MARKET
3.1 Introduction
3.1.1 Background
3.1.2 Neurovascular Devices
3.2 Market Analysis
3.2.1 Market Sizing (Actual & Forecasted)
3.2.2 Market Share by Region
3.2.3 Market Share by Therapeutic Application
3.2.4 Market Share by Technique
4. GLOBAL NEUROVASCULAR MARKET SEGMENTATION
4.1 Cerebral Thrombectomy Devices
4.1.1 Overview
4.1.2 Market Sizing (Actual & Forecasted)
4.1.3 Market Share by Region
4.2 Flow Diverter for Aneurysm
4.2.1 Overview
4.2.2 Market Sizing
4.2.3 Market Share
4.3 Carotid Artery Stenting (CAS) System
4.3.1 Overview
4.3.2 Market Sizing
4.3.3 Market Share by Region
5. THE US NEUROVASCULAR INTERVENTION MARKET
5.1 Market Analysis
5.1.1 Market Sizing (Actual & Forecasted)
5.1.2 Market Share by Segment
5.2 Market Segmentation
5.2.1 Cerebral Thrombectomy Devices Market Sizing (Actual & Forecasted)
5.2.2 Carotid Artery Stenting (CAS) Systems Devices Market Sizing (Actual & Forecasted)
5.2.3 Carotid Artery Stenting (CAS) Systems Devices Market Sizing (Actual & Forecasted)
6. GLOBAL NEUROVASCULAR MARKET DYNAMICS
6.1 Industry Trends & Developments
6.1.1 Mergers & Acquisitions
6.1.2 Technological Advancement
6.1.3 Minimally Invasive Techniques
6.2 Growth Drivers
6.2.1 Rising Prevalence of Cerebrovascular disease
6.2.2 Higher Incidences of Neurological Disorders
6.2.3 Favorable Reimbursement Policies
6.2.4 Expanding Healthcare Infrastructure
6.3 Challenges
6.3.1 High Cost of Treatment
6.3.2 Multiple Product Recalls
6.3.3 Dearth of Skilled Neurosurgeons
6.3.4 Social Stigma
7. COMPETITIVE LANDSCAPE
7.1 Global
7.2 The US
8. COMPANY PROFILES
8.1 Johnson & Johnson DePuy Synthes
8.2 Stryker Corporation
8.3 Medtronic Plc.
8.4 Penumbra Inc.
8.5 Terumo Corporation
2. RESEARCH METHODOLOGY
3. NEUROVASCULAR MARKET
3.1 Introduction
3.1.1 Background
3.1.2 Neurovascular Devices
3.2 Market Analysis
3.2.1 Market Sizing (Actual & Forecasted)
3.2.2 Market Share by Region
3.2.3 Market Share by Therapeutic Application
3.2.4 Market Share by Technique
4. GLOBAL NEUROVASCULAR MARKET SEGMENTATION
4.1 Cerebral Thrombectomy Devices
4.1.1 Overview
4.1.2 Market Sizing (Actual & Forecasted)
4.1.3 Market Share by Region
4.2 Flow Diverter for Aneurysm
4.2.1 Overview
4.2.2 Market Sizing
4.2.3 Market Share
4.3 Carotid Artery Stenting (CAS) System
4.3.1 Overview
4.3.2 Market Sizing
4.3.3 Market Share by Region
5. THE US NEUROVASCULAR INTERVENTION MARKET
5.1 Market Analysis
5.1.1 Market Sizing (Actual & Forecasted)
5.1.2 Market Share by Segment
5.2 Market Segmentation
5.2.1 Cerebral Thrombectomy Devices Market Sizing (Actual & Forecasted)
5.2.2 Carotid Artery Stenting (CAS) Systems Devices Market Sizing (Actual & Forecasted)
5.2.3 Carotid Artery Stenting (CAS) Systems Devices Market Sizing (Actual & Forecasted)
6. GLOBAL NEUROVASCULAR MARKET DYNAMICS
6.1 Industry Trends & Developments
6.1.1 Mergers & Acquisitions
6.1.2 Technological Advancement
6.1.3 Minimally Invasive Techniques
6.2 Growth Drivers
6.2.1 Rising Prevalence of Cerebrovascular disease
6.2.2 Higher Incidences of Neurological Disorders
6.2.3 Favorable Reimbursement Policies
6.2.4 Expanding Healthcare Infrastructure
6.3 Challenges
6.3.1 High Cost of Treatment
6.3.2 Multiple Product Recalls
6.3.3 Dearth of Skilled Neurosurgeons
6.3.4 Social Stigma
7. COMPETITIVE LANDSCAPE
7.1 Global
7.2 The US
8. COMPANY PROFILES
8.1 Johnson & Johnson DePuy Synthes
8.2 Stryker Corporation
8.3 Medtronic Plc.
8.4 Penumbra Inc.
8.5 Terumo Corporation
